Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on sale of Millennuim Media Group
Mandate

Vinge advises on sale of Millennuim Media Group

August 18, 2010

Vinge is advising the shareholders of Millennium Media Group AB (“MMG”) in connection with the sale of their shares in MMG to Turner Broadcasting Europe, a subsidiary of Time Warner. MMG is a media house which currently runs TV channels in 53 countries through its subsidiary, NonStop Television. The channels include Showtime, TV 7, Star! and Silver. The operations also include film distribution, rights sales and subtitling services. The sale is conditional upon competition authority clearance and other customary closing conditions.

Vinge’s team advising the sellers consists of partner Johan Winnerblad and, among others, associates Petter Kjöllerström and Philip Watson as well as project assistant Sara Andersson. Partner Per Eric Alvsing is providing advice on media law issues, associate Louise Brorsson Salomon is advising on financing issues and associate Carl Johan Sundqvist is providing competition law advice.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025